CAMBRIDGE, Masss. and LONDON, Oct. 23, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today ...

CAMBRIDGE, United Kingdom and MONTREAL, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, ...

The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

Infosys is collaborating with the University of Cambridge to establish a new Al Lab in London. This lab aims to harness the ...

SCI Semiconductor are very pleased to announce the global-first CHERI-enabled family of devices, based on the RISC-V RV32E ...

Astex Pharmaceuticals, a pharmaceutical company based in Cambridge, UK, dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous ...

A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...

Virax Biolabs enters distribution agreement with Europa Biosite to commercialize ImmuneSelect in UK & Ireland: London Thursday, October 24, 2024, 12:00 Hrs [IST] Virax Biolabs Gro ...

The Infosys Living Labs located in London's world-renowned banking district of Canary Wharf will enable a confluence of ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with ...